Docusign, Inc.: Form 10-Q for the period ended Oct 31, 2019
Filed with the SEC on Dec 6, 2019 and accepted by EDGAR at Dec 6, 2019, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-08-01 to 2019-10-31 | $249.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2019-02-01 to 2019-10-31 | $699.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-08-01 to 2019-10-31 | $62.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-02-01 to 2019-10-31 | $175.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-08-01 to 2019-10-31 | $187.5m | us-gaap:GrossProfit |
| Gross profit | 9 months2019-02-01 to 2019-10-31 | $523.9m | us-gaap:GrossProfit |
| Research and development | 3 months2019-08-01 to 2019-10-31 | $48.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2019-02-01 to 2019-10-31 | $133.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2019-08-01 to 2019-10-31 | −$44.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-02-01 to 2019-10-31 | −$151.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-08-01 to 2019-10-31 | $7.4m | us-gaap:InterestExpense |
| Interest expense | 9 months2019-02-01 to 2019-10-31 | $21.8m | us-gaap:InterestExpense |
| Income tax | 3 months2019-08-01 to 2019-10-31 | $1.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-02-01 to 2019-10-31 | $3.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-08-01 to 2019-10-31 | −$46.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-02-01 to 2019-10-31 | −$161.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-08-01 to 2019-10-31 | −$0.26 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2019-02-01 to 2019-10-31 | −$0.92 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2019-02-01 to 2019-10-31 | $70.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2019-02-01 to 2019-10-31 | $42.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2019-10-31 | $197.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-10-31 | $869.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-10-31 | $1.79bn | us-gaap:Assets |
| Current liabilities | At period end2019-10-31 | $588.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-10-31 | $1.22bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-10-31 | $569.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001261333-19-000108. Last ingested by Listed: Nov 5, 2026, 13:21 ET. Listed shows no prices and gives no investment advice.